NextFin News — Laike Brothers AI Group, in collaboration with Carephar Pharmaceuticals—a subsidiary of the top-100 pharmaceutical enterprise Xinsongfu Group—announced on Thursday the launch of "Dafu," the world’s first AI immune health big data model.
The "Dafu" model is built upon the proprietary HeyBro large model architecture and integrates over 1.5 million immune cell sample data points alongside a 5-million-level medical knowledge graph. Tailored through domain-specific fine-tuning, the architecture has already been deployed across several physical hardware products, including AI-powered smart pulse diagnostic devices. Laike Brothers AI Group has independently developed its entire core technical infrastructure, which features the 67-billion-parameter HeyBro multimodal vertical large model and the Haibro AI Agent operating system. The Haibro system has already deployed 256 specialized agents to automate full-chain corporate operations, including marketing, administrative workflows, customer service, and executive decision-making.
The deployment of multi-billion-parameter vertical models within the healthcare sector underscores a structural shift toward combining highly specialized clinical datasets with physical diagnostic hardware on the Chinese mainland. By fine-tuning foundational multi-modal architectures on dense biological and diagnostic profiles, developers are moving past generic conversational software into high-precision, localized medical applications. For life sciences investors and pharmaceutical executives, this integration of agentic operating systems across enterprise operational flows and clinical data analysis represents a key strategy to reduce R&D cycle frictions, lower computational deployment costs, and commercialize proprietary healthcare datasets.
Explore more exclusive insights at nextfin.ai.
